Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Actuarial Approach

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

Applications of Life Tables

Applications of Life Tables

Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...

Life Tables

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...

Estimation of the Physical Quantities

Estimation of the Physical Quantities

On many occasions, physicists, other scientists, and engineers need to make estimates of a particular quantity. These are sometimes referred to as guesstimates, order-of-magnitude approximations, back-of-the-envelope calculations, or Fermi calculations. The physicist Enrico Fermi was famous for his ability to estimate various kinds of data with surprising precision. Estimating does not mean guessing a number or a formula at random. Instead, estimation means using prior experience and sound...

Stages of General Anesthesia

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Addressing genetic discrimination and its stigmatizing effects through human rights.

Journal of community genetics·2026

Same author

A call for a global cyberbiosecurity framework in genomics.

Nature genetics·2025

Same author

Communicating clearly about data sharing in genomics.

Human genomics·2025

Same author

The Key Features of a Genetic Nondiscrimination Policy: A Delphi Consensus Statement.

JAMA network open·2024

Same author

The advent of forensic DNA databases: It's time to agree on some international governance principles!

Forensic science international. Genetics·2024

Same author

A proposal for an inclusive working definition of genetic discrimination to promote a more coherent debate.

Nature genetics·2024

Same journal

What Makes a Good Physician? Asclepius and the Rhetoric of AI.

AMA journal of ethics·2025

Same journal

Response to "Response to 'Is the UDN N-of-1 Enterprise Ethically Justifiable?'".

AMA journal of ethics·2025

Same journal

Patient Voices on Diagnostic Research.

AMA journal of ethics·2025

Same journal

Response to "Is the UDN N-of-1 Enterprise Ethically Justifiable?"

AMA journal of ethics·2025

Same journal

Great Lakes Eutrophication and Respiratory Health Harms.

AMA journal of ethics·2025

Same journal

Lessons for Responsible Geroscience From the History of Longevity.

AMA journal of ethics·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 7, 2026

Measurement of Lifespan in Drosophila melanogaster

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

How Old Are You, Actuarily?

Abby Rud¹, Diya Uberoi²

¹Research assistant at the Genetic Discrimination Observatory and the Centre of Genomics and Policy.

AMA Journal of Ethics

|December 18, 2025

Summary

This summary is machine-generated.

Epigenetic age estimation improves health insurance risk assessment but raises ethical concerns. Current laws like Canada's Genetic Non-Discrimination Act (GNDA) struggle to keep pace with technological advancements, necessitating adaptable legal strategies.

More Related Videos

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS

Published on: July 30, 2020

Related Experiment Videos

Last Updated: Jan 7, 2026

Measurement of Lifespan in Drosophila melanogaster

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS

Published on: July 30, 2020

Area of Science:

Biotechnology and Bioinformatics
Actuarial Science and Risk Management
Bioethics and Law

Background:

Epigenetic age estimation offers precise health risk assessment for insurance underwriting.
This application raises significant ethical and legal challenges concerning data privacy, discrimination, and equity.
Existing legal frameworks may not adequately address the rapid evolution of epigenetic technologies.

Purpose of the Study:

To examine the regulatory limitations of Canada's Genetic Non-Discrimination Act (GNDA) in the context of epigenetic age estimation.
To highlight the inadequacy of current legislation in addressing novel bioethical and legal issues.
To advocate for the development of more adaptable legislative strategies for emerging biotechnologies.

Main Methods:

Analysis of Canada's Genetic Non-Discrimination Act (GNDA) provisions.
Review of current epigenetic age estimation technologies and their applications in actuarial science.
Comparative legal and ethical analysis of legislative responses to genetic and epigenetic data.

Main Results:

The GNDA, while protective, exhibits limitations in its scope and adaptability to rapidly advancing epigenetic technologies.
Current legal structures are insufficient to preemptively address all potential discriminatory uses of epigenetic data in insurance.
A gap exists between the pace of technological innovation and the evolution of legal safeguards.

Conclusions:

Legislation must become more agile to effectively govern the use of epigenetic data in risk assessment.
Broader ethical guidelines and adaptable legal frameworks are crucial to ensure equity and prevent discrimination.
Future legal strategies should proactively anticipate and accommodate advancements in biological data utilization.